[1] YANG P,YANG L,DONG YM.Impact of intraoperative frozen section pathology on the treatment outcome of unilateral papillary thyroid microcarcinoma and its influencing factors-a retrospective cohort study[J].Gland Surg,2022,11(10):1656-1664.
[2] 高少阳,王明伟,张盛,等.建立优化的术中快速免疫组化检测体系[J].临床与实验病理学杂志,2021,37(1):108-109.
GAO SY,WANG MW,ZHANG S,et al.Establishment of an optimized intraoperative rapid immunohistochemical detection system[J].Chinese Journal of Clinical and Experimental Pathology,2021,37(1):108-109.
[3] LOUIS DN,PERRY A,WESSELING P,et al.The 2021 WHO Classification of Tumors of the Central Nervous System:a summary [J].Neuro Oncol,2021,23(8):1231-1251.
[4] LIU M,ZHAO SQ,YANG L,et al.A direct immunohistochemistry (IHC) method improves the intraoperative diagnosis of breast papillary lesions including breast cancer [J].Discov Med,2019,28(151):29-37.
[5] ABOUSHOUSHA T,MAMDOUH S,HAMDY H,et al.Immunohistochemical and biochemical expression patterns of TTF-1,RAGE,GLUT-1 and SOX2 in HCV-associated hepatocellular carcinomas [J].Asian Pac J Cancer Prev,2018,19(1):219-227.
[6] 刘梅,李席如,宋欣,等.术中快速直接免疫组化在乳腺病变和前哨淋巴结诊断中的应用[J].诊断病理学杂志,2018,25(03):170-176.
LIU M,LI XR,SONG X,et al.Rapid immunohistochemistry in the diagnosis of breast lesions and sentinel lymph nodes[J].Chinese Journal of Diagnostic Pathology,2018,25(03):170-176.
[7] ZHANG XB,LIU JY,YAN XL.Rapid intraoperative immunocytochemistry of central nervous system tumors[J].Int J Clin Exp Pathol,2020,13(1):44-48.
[8] CHAGANTI J,TAYLOR M,WOODFORD H,et al.Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-derived metrics:Pilot study[J].World Neurosurg,2021,151:e979-e987.
[9] OSTROM QT,GITTLEMAN H,LIAO P,et al.CBTRUS statistical report:Primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014[J].Neuro Oncol,2017,19(suppl_5):v1-v88.
[10] KONING ME,HOF JJ,JANSEN C,et al.Primary central nervous system lymphoma [J].J Neuro,2024,271(5):2906-2913.
[11] ZHU T,XIE P,GAO YF,et al.Nucleolar and spindle-associated protein 1 is a tumor grade correlated prognosis marker for glioma patients [J].CNS Neurosci Ther,2018,24(3):178-186.
[12] GAO LM,ZHANG MC,ZHANG Y,et al.Progress of radiological pathological workflows in the differential diagnosis between primary central nervous system lymphoma and high grade glioma (review)[J].Oncol Rep,2023,49(1):20.
[13] LI J,WANG Y,MENG X,et al.Modulation of transcriptional activity in brain lower grade glioma by alternative splicing [J].PeerJ,2018,6:e4686.
[14] STITZLEIN LM,ADAMS JT,STITZLEIN EN,et al.Current and future therapeutic strategies for high-grade gliomas leveraging the interplay between epigenetic regulators and kinase signaling networks [J].J Exp Clin Cancer Res,2024,43(1):12.
[15] 王沛沛,李金凯,李彩虹,等.脑胶质瘤放疗计划设计的探索和评价[J].现代肿瘤医学,2023,31(18):3442-3446.
WANG PP,LI JK,LI CH,et al.Exploration and evaluation of the radiotherapy plan for glioma[J].Modern Oncology,2023,31(18):3442-3446.
[16] SHARMA K,SINGH J,FROST EE,et al.MeCP2 overexpression inhibits proliferation,migration and invasion of C6 glioma by modulating ERK signaling and gene expression [J].Neurosci Lett,2018,674:42-48.
[17] PINCHI E,FRATI A,CIPOLLONI L,et al.Clinical-pathological study on β-APP,IL-1β,GFAP,NFL,Spectrin II,8OHdG,TUNEL,miR-21,miR-16,miR-92 expressions to verify DAI-diagnosis,grade and prognosis [J].Sci Rep,2018,8(1):2387.
[18] 虞飞,冯立文,项鹏程,等.不同抗原修复方法在淋巴瘤免疫组化检测中的应用[J].诊断病理学杂志,2019,26(9):622-623.
YU F,FENG LW,XIANG PC,et al.Application of different antigen repair methods in immunohistochemical detection of lymphoma[J].Chinese Journal of Diagnostic Pathology,2019,26(9):622-623.